Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice

Oncology Reports

Volumn 26, Issue 1, 2011, Pages 247-254

  Peters, S J ^a,e   Van Helvoort, A ^a   Kegler, D ^a   Argiles J M ^b   Luiking, Y C ^a,d   Laviano, A ^c   Van Bergenhenegouwen, J ^a   Deutz, N E P ^d   Haagsman, H P ^e   Gorselink, M ^f   Van Norren, K ^a,f  

^a DANONE RESEARCH   (Netherlands)

^b UNIVERSITY OF BARCELONA   (Spain)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

^f WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Cachexia; Fatigue; Leucine; Protein metabolism

Indexed keywords

ALANINE; ARGININE; ASPARAGINE; GLYCINE; ISOLEUCINE; LEUCINE; LYSINE; MESSENGER RNA; SERINE; TAURINE; VALINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CACHEXIA; CANCER CACHEXIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXTENSOR DIGITORUM LONGUS MUSCLE; GASTROCNEMIUS MUSCLE; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TUMOR VOLUME;

AMINO ACIDS; ANIMALS; CACHEXIA; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUCINE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MUSCLE PROTEINS; MUSCLES; NEOPLASM TRANSPLANTATION; NEOPLASMS;

EID: 79955828066     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1269     Document Type: Article

References (55)

1. Argiles JM: Cancer-associated malnutrition. Eur J Oncol Nurs 9: S39-S50, 2005.
2. Kotler DP: Cachexia. Ann Intern Med 133: 622-634, 2000.
3. Fearon KC, Voss AC and Hustead DS: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83: 1345-1350, 2006.
4. Melstrom LG, Melstrom KA Jr, Ding XZ and Adrian TE: Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 22: 805-814, 2007. (Pubitemid 47034146)
5. Dimitriu C, Martignoni ME, Bachmann J, Frohlich B, Tintarescu G, Buliga T, Lica I, Cbnstantinescu G, Beuran M and Friess H: Clinical impact of cachexia on survival and outcome of cancer patients. Rom J Intern Med 43: 173-185, 2005.
6. Argiles JM, Busquets S, Felipe A and Lopez-Soriano FJ: Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol 18: 39-54, 2006.
7. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS and Kimball SR: Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130: 2413-2419, 2000.
8. Anthony JC, Anthony TG, Kimball SR and Jefferson LS: Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 131: S856-S860, 2001.
9. Eley HL, Russell ST and Tisdale MJ: Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochem J 407: 113-120, 2007. (Pubitemid 47535586)
10. Gomes-Marcondes MC, Ventrucci G, Toledo MT, Cury L and Cooper JC: A leucine-supplemented diet improved protein content of skeletal muscle in young tumor-bearing rats. Braz J Med Biol Res 36: 1589-1594, 2003. (Pubitemid 37408048)
11. Emery PW, Edwards RH, Rennie MJ, Souhami RL and Halliday D: Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed) 289: 584-586, 1984. (Pubitemid 14009869)
12. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, Rossi Fanelli F, Doglietto GB and Baccino FM: Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 237: 384-389, 2003. (Pubitemid 38176454)
13. Ventrucci G, Mello MA and Gomes-Marcondes MC: Proteasome activity is altered in skeletal muscle tissue of tumour-bearing rats a leucine-rich diet. Endocr Relat Cancer 11: 887-895, 2004. (Pubitemid 40065560)
14. Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, Kimball SR and Jefferson LS: Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am J Physiol Endocrinol Metab 282: E1092-1E101, 2002.
15. Anthony JC, Reiter AK, Anthony TG, Crozier SJ, Lang CH, MacLean DA, Kimball SR and Jefferson LS: Orally administered leucine enhances protein synthesis in skeletal muscle of diabetic rats in the absence of increases in 4E-BP1 or S6K1 phosphorylation Diabetes 51: 928-936, 2002.
16. Tanaka Y, Eda H, Tanaka T, Udagawa T, Ishikawa T, Horii I, Ishitsuka H, Kataoka T and Taguchi T: Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50: 2290-2295, 1990. (Pubitemid 20134483)
17. Diffee GM, Kalfas K, Al-Majid S and McCarthy DO: Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol Cell Physiol 283: C1376-C1382, 2002. (Pubitemid 35178429)
18. Gorselink M, Vaessen SF, van der Flier LG, Leenders I, Kegler D, Caldenhoven E, van der Beek E and van Helvoort A: Mass-dependent decline of skeletal muscle function in cancer cachexia. Muscle Nerve 33: 691-693, 2006.
19. Soda K, Kawakami M, Kashii A and Miyata M: Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer 62: 332-336, 1995.
20. van Norren K, Kegler D, Argiles JM, Luiking Y, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, van der Beek EM and van Helvoort A: Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer 100: 713-722, 2009.
21. Faber J, Vos P, Kegler D, van Norren K, Argiles JM, Laviano A, Garssen J and van Helvoort A: Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br J Cancer 99: 2029-2036, 2008.
22. Reeves PG, Nielsen FH and Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
23. van Eijk HM, Rooyakkers DR and Deutz NE: Rapid routine determination of amino acids in plasma by high-performance liquid chromatography with a 2-3 microns Spherisorb ODS II column. J Chromatogr 620: 143-148, 1993. (Pubitemid 23317657)
24. van Hoorn EC, Sutmuller-Ooms M, De Vrij G, van Leeuwen PA and van Norren K: A fast and accurate method to measure both oxidative stress and vitality in a single organ slice. Anal Biochem 320: 82-87, 2003. (Pubitemid 36937070)
25. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD and Glass DJ: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001. (Pubitemid 33104839)
26. Wyzykowski JC, Winata TI, Mitin N, Taparowsky EJ and Konieczny SF: Identification of novel MyoD gene targets in proliferating myogenic stem cells. Mol Cell Biol 22: 6199-6208, 2002. (Pubitemid 34857839)
27. Wojcik S, Nogalska A, Engel WK and Askanas V: Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy. Folia Morphol (Warsz) 67: 6-12, 2008. (Pubitemid 351404053)
28. Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18: 761-766, 2002.
29. Laurichesse H, Tauveron I, Gourdon F, Cormerais L, Champredon C, Charrier S, Rochon C, Lamain S, Bayle G, Laveran H, Thieblot P, Beytout J and Grizard J: Threonine and methionine are limiting amino acids for protein synthesis in patients with AIDS. J Nutr 128: 1342-1348, 1998. (Pubitemid 28361427)
30. Hill AS, Marks SL and Rogers QR: Quantitation of urinary 3-methylhistidine excretion in growing dogs as an index of in vivo skeletal muscle catabolism. J Nutr Biochem 12: 346-350, 2001. (Pubitemid 32552050)
31. Wang Z, Deurenberg P, Matthews DE and Heymsfield SB: Urinary 3-methylhistidine excretion: association with total body skeletal muscle mass by computerized axial tomography. JPEN J Parenter Enteral Nutr 22: 82-86, 1998. (Pubitemid 28117570)
32. Nagasawa T, Kikuchi N, Ito Y, Yoshizawa F and Nishizawa N: Suppression of myofibrillar protein degradation after refeeding in young and adult mice. J Nutr Sci Vitaminol (Tokyo) 50: 227-230, 2004. (Pubitemid 39045127)
33. Rennie MJ and Millward DJ: 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown. Clin Sci (Lond) 65: 217-225, 1983. (Pubitemid 13076195)
34. Chinkes DL: Methods for measuring tissue protein breakdown rate in vivo. Curr Opin Clin Nutr Metab Care 8: 534-537, 2005.
35. Gutierrez A, Anderstam B and Alvestrand A: Amino acid concentration in the interstitium of human skeletal muscle: a microdialysis study. Eur J Clin Invest 29: 947-952, 1999. (Pubitemid 29532885)
36. Kitzmann M, Carnac G, Vandromme M, Primig M, Lamb NJ and Fernandez A: The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells. J Cell Biol 142: 1447-1459, 1998. (Pubitemid 28452595)
37. Koopman R, Wagenmakers AJ, Manders RJ, Zorenc AH, Senden JM, Gorselink M, Keizer HA and van Loon LJ: Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects. Am J Physiol Endocrinol Metab 288: E645-E653, 2005. (Pubitemid 40397198)
38. Rieu I, Balage M, Sornet C, Giraudet C, Pujos E, Grizard J, Mosoni L and Dardevet D: Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. J Physiol 575: 305-315, 2006. (Pubitemid 44182713)
39. Koopman R, Verdijk L, Manders RJ, Gijsen AP, Gorselink M, Pijpers E, Wagenmakers AJ and van Loon LJ: Co-ingestion of protein and leucine stimulates muscle protein synthesis rates to the same extent in young and elderly lean men. Am J Clin Nutr 84: 623-632, 2006. (Pubitemid 44713414)
40. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A and Wolfe RR: A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 291: E381-E387, 2006. (Pubitemid 44035298)
41. Argiles JM, Alvarez B and Lopez-Soriano FJ: The metabolic basis of cancer cachexia. Med Res Rev 17: 477-498, 1997.
42. Dodesini AR, Benedini S, Terruzzi I, Sereni LP and Luzi L: Protein, glucose and lipid metabolism in the cancer cachexia: A preliminary report. Acta Oncol 46: 118-120, 2007.
43. Saini A, Al-Shanti N and Stewart CE: Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev 17: 475-486, 2006. (Pubitemid 44793120)
44. Bruins MJ, Deutz NE and Soeters PB: Aspects of organ protein, amino acid and glucose metabolism in a porcine model of hypermetabolic sepsis. Clin Sci (Lond) 104: 127-141, 2003. (Pubitemid 36238045)
45. Cangiano C, Laviano A, Meguid MM, Mulieri M, Conversano L, Preziosa I and Rossi-Fanelli F: Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst 88: 550-552, 1996. (Pubitemid 126613359)
46. Laviano A, Muscaritoli M, Cascino A, Preziosa I, Inui A, Mantovani G and Rossi-Fanelli F: Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care 8: 408-414, 2005.
47. Biolo G, De Cicco M, Dal Mas V, Lorenzon S, Antonione R, Ciocchi B, Barazzoni R, Zanetti M, Dore F and Guarnieri G: Response of muscle protein and glutamine kinetics to branched-chain-enriched amino acids in intensive care patients after radical cancer surgery. Nutrition 22: 475-482, 2006.
48. Hiroshige K, Sonta T, Suda T, Kanegae K and Ohtani A: Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant 16: 1856-1862, 2001.
49. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F and Abbiati R: Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124: 1792-1801, 2003. (Pubitemid 36666776)
50. Laviano A, Meguid MM, Inui A and Rossi-Fanelli F: Role of leucine in regulating food intake. Science 313: 1236-1238; author reply 1236-1238, 2006.
51. Barber MD, Fearon KC, Tisdale MJ, McMillan DC and Ross JA: Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 40: 118-124, 2001. (Pubitemid 34274917)
52. Barber MD, Ross JA, Voss AC, Tisdale MJ and Fearon KC: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81: 80-86, 1999.
53. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S and Christensen B: An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22: 2469-2476, 2004. (Pubitemid 41115406)
54. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC and Fearon KC: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12: S27-S30, 1996.
55. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ and Fearon KC: Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36: 177-184, 2000. (Pubitemid 30437038)